Investment Pitches

Pitch Summary:
Caribou Bioscience uses advanced CRISPR technologies to develop new and targeted cancer treatments. These allogenic (i.e. non-individualised) CART therapies use ad­vanced gene editing techniques to improve the immune response and increase anti-tumour activity.

BSD Analysis:
Caribou Biosciences has recently been upgraded to a "Buy" (Zacks Rank #2), reflecting a significant upward trend in earnings estimate revisions that historically precedes a move higher in share price. The company is benefiting from its specialized "chRDNA" genome-editing technology, which provides a competitive edge in developing highly specific and persistent cell therapies. Analysts have steadily raised their estimates for 2025 and 2026, signaling that institutional investors are beginning to recalculate the fair value of the firm's oncology pipeline. For the Buyside Digest, Caribou represents a tactical biotech pick with superior earnings revision features, making it a solid candidate for producing market-beating returns as clinical data matures.

Pitch Summary:
Crispr Therapeutics, whose founders include Nobel Prize laureate Emmanuelle Charpentier, is the leader in genome editing technology and offers ground-breaking treatment options for genetic diseases. At first, the earnings will come from Vertex Pharmaceuticals. CRISPR Therapeutics and Vertex Phar­maceuticals share the costs and profits of CASGEVY at a ratio of 40:60. This treatment aims to cure genetic diseases such as sickle cell anaemia and transfusion-dependent beta thalassemia through gene editing.

BSD Analysis:
CRISPR Therapeutics is riding a wave of investor confidence in early 2026, with the stock surging 11% following the successful market introduction of its gene-editing therapy, Casgevy. Despite short-term earnings volatility, the company maintains a fortress balance sheet and strong institutional support from firms like ARK Investment Management. Collaboration revenues from the Vertex Pharmaceuticals partnership are beginning to provide a more stable financial footing as the firm advances its late-stage immuno-oncology and autoimmune pipelines. Currently viewed as undervalued by several major analysts, CRISPR remains the gold standard for gene-editing investment, offering deep-value optionality across its groundbreaking medicinal platform.

Pitch Summary:
After a long absence, Grenke is back in the fund. We expect that the financing specialist for the mid-size sector will return to profitability: future profits should see good growth as the new business picks up. At this time, the share price trades at a discount to the book value.

BSD Analysis:
Grenke AG has started 2026 on a high note, meeting its annual guidance with €3.3 billion in leasing new business and securing €200 million in government-sponsored funding to support SMEs. The company is experiencing a significant earnings recovery, with Q3 2025 group earnings more than doubling year-over-year to €22.4 million as risk provisions and claim expenses normalize. Management’s focus on digitalization and climate protection infrastructure has driven a 10.6% growth in leasing new business, maintaining a healthy CM2 margin of 16.7%. For value-oriented investors, Grenke offers a stable, high-margin exposure to the essential financing of European small-to-mid-sized enterprises during a period of infrastructure modernization.

Pitch Summary:
The fact that sporting goods giant Nike had to revise its annual forecasts also had a negative effect on other sporting good stocks. Atlanta Sports in particular, the disappointing results in the online business and weak demand in the Chinese market (Anta Sports’ main sales market) created considerable uncertainty among investors. Overall, however, the company still expects strong revenue and profit growth for the year 2024.

BSD Analysis:
ANTA Sports remains the premier "Alpha" play in the global sportswear market, entering 2026 with a disciplined growth strategy that blends its core brand dominance with the strategic acquisition of Jack Wolfskin. The company is forecast to grow annual earnings and revenue by approximately 6.7% and 8.3% respectively, with a target return on equity (ROE) of 20% over the next three years. While trading volume remains robust at over 5.6 million shares daily, the stock offers a reliable yield through its consistent final dividend policy. As the leading sports brand in the world’s largest consumer market, ANTA is successfully capturing the "premiumization" trend in Chinese athletics, making it a cornerstone for portfolios seeking exposure to Asian consumer discretionary growth.

Pitch Summary:
In the last quarter, Fortescue Metals saw less de­mand for iron ore and had to adjust its forecast for the current year. At the same time, the company remains both profitable and attractive with an expected dividend yield of over 8%. Management affirmed its goal of becoming climate-neutral by 2030.

BSD Analysis:
Fortescue is iron ore leverage with a balance sheet and cost curve that let it survive what kills higher-cost peers. Investors treat it as pure China construction beta and ignore its position as a top-tier low-cost producer. When iron ore prices wobble, sentiment collapses faster than fundamentals. Cash generation in strong markets funds dividends that are anything but symbolic. The green energy pivot grabs headlines, but the core mining franchise still drives value. Cost discipline and scale matter more than commodity narratives. This is bulk commodity exposure with operating torque and capital return discipline. When iron ore tightens, Fortescue doesn’t need heroics to print cash.

Pitch Summary:
The company's share price was once again hit by setbacks in clinical research. Our portfolio management team recently visited the labs in Mainz to get a better picture of the company. In our opinion, the well-stocked pipeline is very promising, even if setbacks are part of the business, and the introduction of the first cancer treatments starting in 2026 is also a realistic scenario. Liquidity of around EUR 16 billion with a market cap of less than EUR 18 billion shows the capital market's current lack of interest in BioNTech.

BSD Analysis:
BioNTech has officially designated 2026 as its "Clinical Execution Year," shifting focus from COVID-19 revenue to a massive late-stage oncology and mRNA-based infectious disease pipeline. The company is currently trading near $108, with institutional analysts setting 12-month objectives in the low-$140s as investors await pivotal data readouts from its cancer vaccine programs. With a fortress cash position and an R&D budget targeted at rapid portfolio expansion, BioNTech remains a foundational biotech holding for those seeking exposure to the next decade of genomic medicine. The stock’s rebound from late-2025 lows suggests that the market has finally priced in the post-pandemic reset and is now valuing the company for its robust oncology IP and platform scalability.

Pitch Summary:
In May, the company released a revenue forecast that was below market expectations but still showed positive developments. Despite the challenges due to Apple’s reduced order volume for the next iPhone generation, the manufacturer of radio fre­quency chips was able to make up for the stock market losses in June, as the company is making good progress in aligning its product offering to a wider customer base.

BSD Analysis:
Skyworks Solutions is currently a high-conviction "merger-and-recovery" play in the semiconductor space, following its blockbuster proposed merger with Qorvo aimed at realizing $500 million in annual synergies. For Q1 FY2026, the company surpassed earnings expectations with an EPS of $1.54 on $1.04 billion in revenue, driven by a shortening smartphone replacement cycle and early engagements in Wi-Fi 8 programs. While mobile revenue is expected to see some sequential seasonal decline, the "Broad Markets" segment—specifically automotive and aerospace—is stabilizing the bottom line. The stock offers a defensive 33% free cash flow margin and a strong cash position of $1.6 billion, positioning it to dominate the RF (Radio Frequency) front-end market as AI processing moves closer to the edge in consumer devices.

Pitch Summary:
Palantir continues to expand its activi­ties. In addition to orders from the defence sector, Palantir also an­nounced a significant cooperation in the aerospace sector. Voyager Space, a global leader in aerospace research, announced a strategic partnership with Palantir. Voyager will use Palantir Foundry and the AIP platform for artificial intelligence to improve the company's payload management system for the clients of the International Space Station (ISS) and the future commercial Starlab space station.

BSD Analysis:
Palantir has officially transitioned from a speculative growth story to a dominant S&P 500 powerhouse, entering 2026 with a massive 70% year-over-year surge in Q4 revenue to $1.41 billion. The investment thesis is now firmly anchored in its Commercial AIP (AI Platform) and sustained US government demand, which recently drove quarterly government contract revenue up 66% to roughly $570 million. While the stock has experienced short-term volatility in February 2026, trading near the $145 level, broker sentiment is increasingly bullish, with Citi upgrading the stock to a "Buy" and raising its price target to $235. Management’s 2026 guidance materially exceeded consensus, signaling that Palantir is successfully capturing the lion's share of enterprise-grade AI integration as companies move beyond LLM experimentation into operational reality.

Pitch Summary:
KLX is a service company for the oil and gas sector in the United States. The company suffered greatly during the pandemic years due to the sharp drop in investment during those years. However, in recent years it has seen a very substantial improvement in its business, has consolidated several companies by strengthening its service offering and has managed to significantly reduce its leverage to very reasonable levels. Despite this, the share price has experienced a very substantial drop in recent months to almost historic lows due to a certain slowdown in production activity in the United States in recent months. However, our medium-term outlook remains positive, and we have again strengthened our position in this company.

BSD Analysis:
KLX’s moat is niche oilfield services scale in basins where relationships drive repeat work. It remains hostage to E&P spending cycles. Pricing improves only when capacity tightens. Capital intensity punishes mis-timed expansion. Leverage amplifies commodity swings. Differentiation is operational, not structural. Consolidation helps pricing discipline temporarily. The bull case is sustained drilling activity. KLX is pure cycle leverage.

Pitch Summary:
Headlam is a British flooring products distribution company (mainly carpet) leader in the UK market. The company has been trading in the region of £4 per share for the last ten years yet has recently fallen to current levels of £1.4. It is a very cash generative company with little debt and has temporarily experienced a fall in sales and earnings as falling consumer confidence in the UK is affecting demand for these types of products. However, once this situation of falling demand ends, we are convinced that the company will recover its historical level of results, and this should gradually be reflected in the share price. In the meantime, as there is no balance sheet risk, the outlook is good.

BSD Analysis:
Headlam’s moat is distribution density in UK flooring where logistics scale matters. It’s a volume business tied to housing and refurbishment cycles. Pricing power is thin; cost control defines returns. Consolidation helps, but doesn’t eliminate cyclicality. Inventory management determines survival in downturns. Operating leverage cuts both ways. Customer fragmentation provides resilience but not growth acceleration. The bull case is housing recovery with disciplined cost management. Headlam survives on efficiency.

Pitch Summary:
During the second quarter we made an investment in the UK company Keywords Studios Plc. This is the largest service company for the video games industry. In the video games industry in recent years there has been a strong trend for video game publishers to outsource many of the services required for the launch of new products. These services include game creation, adaptation and localisation services, and marketing and launch activities. Keywords, over the last few years, was experiencing very significant growth, benefiting from the tailwind of this outsourcing process in the industry and complemented by a process of consolidation through acquisitions in a sector that was highly fragmented and without major players. In this sense, although Keywords is the largest player (more than three times larger than the next competitor), its market share is only 6%. All this had allowed it to experience earnings per share growth of 29% per annum in the period from 2017 to 2023. In addition, it is a highly profitable business with strong cash generation that has allowed the company to finance the various acquisitions it has made. However, although we had known and followed this company for several years, we had never decided to invest because the valuation at which it was trading was excessively high (multiples between 25/30x Enterprise Value / EBITDA). However, in recent quarters the company experienced a sharp fall in the share price due to certain temporary problems (the actor strike in the United States and a certain slowdown in business after a very strong year 2022 as a result of the post-Covid recovery) and a certain fear in the market of the structural damage that artificial intelligence could generate in the future on some of the services that the company offers to its customers. In just six months, the share price fell by 40%, leaving the company at a very attractive price level (around 7x Enterprise Value / EBITDA), a moment that we took advantage of to invest in the company at a price of around 11 pounds per share. Fortunately, at the end of May, just two months after we started investing in the company, Keywords announced that it was in talks with the private equity fund EQT for a possible sale at a price of £25.5 per share, which represented a premium of almost 100% over our purchase price (the recently confirmed firm offer has left the final price at £24.5).

BSD Analysis:
Keywords Studios is well-positioned in 2026 to capitalize on the widening gap between AI-enabled and legacy video game development houses. As the global gaming market scales toward $656 billion by 2033, Keywords is successfully integrating AI as a revenue engine to personalize player experiences and accelerate asset creation for its global client base. Market data suggests that studios combining durable IP with Keywords’ advanced AI-driven outsourcing can command valuation premiums 2-3 times higher than traditional peers. While the work-for-hire model faces some disruption from automation, Keywords’ scale and localized expertise in over 60 countries provide a defensive backstop for its high-margin localization and testing services. For investors, the company represents a strategic "bet on the industry" rather than individual titles, offering diversified exposure to the increasing technical complexity of game development.

Pitch Summary:
With the proceeds, we bought more FICO, which declined significantly because of comments made by Federal Housing Finance Agency Director Bill Pulte. He expressed displeasure over FICO’s aggressive price increases and suggested that the administration is exploring options to reduce FICO’s monopoly power. These comments, FICO’s price reaction, and our decision to increase the position size serve as a good opportunity to discuss an important part of our investment process that we don’t believe we’ve made explicit in past letters. First, a quick refresher: As we’ve stated in the past, we believe investors are avaricious, impatient, and overconfident, leading them to, on average, overprice the most speculative stocks and underprice the most high-quality and durable businesses. Furthermore, since competition and innovation eventually drive down the returns of all businesses, investors rationally price these high-quality businesses as though they will experience some long-term erosion to both their inflation-adjusted product pricing and their returns on capital. However, a select few of these businesses can buck this trend and experience constant or rising inflation-adjusted pricing and returns on invested capital over time. We believe the businesses most likely to accomplish this unlikely feat 1) own a dominant network; 2) possess additional checks on competing supply such as not-in-my-backyard zoning restrictions and institutional risk aversion; 3) operate in a category likely to grow at least as fast as GDP; 4) possess untapped pricing power; 5) have a conservative balance sheet; and 6) are run by an ownership-minded management team. The first four characteristics give the businesses enduring pricing power and the last two characteristics increase the probability that we, as minority shareholders, will benefit from the business value growth that this enduring pricing power is likely to create over time. This combination of enduring pricing power and strong shareholder protections against bankruptcy and dilution creates what we believe to be a uniquely favorable risk-adjusted return setup. Since investors expect pricing and returns on capital to deteriorate but we believe these businesses have a much higher-than-average probability of maintaining or increasing their prices and returns on invested capital, we believe they are much more likely to surprise investors to the upside than the downside over the long term. Moreover, we believe the magnitude of these upside surprises is likely to be larger, on average, than the downside surprises. In other words, we believe long-term equity ownership of these businesses is positively convex. However, this analysis makes one key assumption. It assumes that governments will allow our businesses to price for the value they create over time. If they don’t, through mechanisms such as regulation, taxation, or bargaining power, then we believe equity ownership in these businesses is no longer positively convex. Therefore, to own a business, we must believe it’s unlikely governments will cap long-term pricing and returns on capital. The key phrase in this sentence is “long-term.” If history is any guide, we should expect periods of

BSD Analysis:
FICO’s selloff after the FHFA comments was a classic case of investors panicking first and thinking later. The idea that regulators are about to dismantle FICO’s scoring dominance ignores decades of institutional inertia and the reality that lenders, agencies, and secondary markets prefer standardization over experimentation. Even if Washington grumbles about pricing power, the odds of the government engineering a viable alternative at scale are low, especially when the entire mortgage ecosystem is hardwired into FICO’s models. The company still checks every box of a rare pricing-power compounder, from its network effects to the structural barriers that keep rivals from gaining traction. Investors routinely underestimate how durable FICO’s economics are and overestimate how fast political pressure translates into structural change. The balance sheet is clean, the business model is capital light, and management behaves like owners who understand the long game. What the market calls “regulatory risk” often ends up being background noise for firms with embedded adoption and system-level reliance. Adding on weakness makes sense because this is exactly the kind of business that surprises to the upside once the headline dust settles.

Pitch Summary:
LSEG's business encompasses various segments, including Data & Analytics, Risk Intelligence, Capital and Post Trade services. As the largest provider, globally, of real time price data and non-real time data, this information feeds into its other divisions enhancing its competitive advantage by creating a ‘winner takes most’ network effect. 70% of revenues are also recurring in nature, which helps to support the persistency of the business model. LSEG’s recent partnership with Microsoft looks set to revolutionise the way that information is collated and analysed. The moat or barrier here for LSEG, is its control of the data that is feeding into this new Artificial Intelligence technology.

BSD Analysis:
LSEG combines recurring data revenues, high switching costs, and growing AI-enabled workflows into a powerful compounding model. Shares trade at ~22–24x forward earnings, justified by mid-single-digit organic growth and expanding operating leverage. The Microsoft partnership is a material catalyst, potentially accelerating adoption of integrated analytics and workflow solutions. With strong cash generation and disciplined M&A integration, long-term returns on capital should improve. The key risks include regulatory scrutiny and competition from alternative data providers.

Pitch Summary:
Margins and returns have come under pressure because of the impact of Covid on its business, not least its Out of Home (OoH) division, which due to a change in accounting treatment has experienced a write-down in value of this cash generating unit (CGU). This has led to a restructuring of this division with a greater focus on improving profitability rather than growth. Whilst we think these developments are welcome, we believe there are better places to deploy capital in the fund. Liquidity was also a concern as the fund’s size has grown substantially, making the original weighting less practical. Competition for capital has effectively squeezed Nichols plc from the fund.

BSD Analysis:
Nichols has struggled with declining ROIC and margin compression post-Covid, and despite restructuring efforts, revenue visibility remains weak. Shares trade at modest valuation multiples (P/E ~14–16x), but growth prospects are muted and competitive intensity in soft drinks remains high. Limited liquidity also makes it less suitable for larger institutional portfolios. The fund’s exit is consistent with a disciplined capital-allocation framework prioritizing higher-quality, higher-return names.

Pitch Summary:
Autozone, O’Reilly and Advance Auto Parts are the three largest companies in what is considered a mature market. So no major new competition has been attracted into this market over recent years. Due to being in a ‘boring’ sector, the stock valuation hasn’t traded on a particularly high valuation rating over the last twenty years. As a result, management have bought back around 90% of their shares in issue—which has increased earnings per share dramatically over this period. Earnings per share has grown over 20% each year on average for two decades.

BSD Analysis:
Autozone is the kind of company that proves you don’t need a sexy industry to produce elite shareholder returns; you just need an unshakeable competitive position and a management team that knows how to play the long game. The entire auto-parts retail market is so mature and unglamorous that no serious new entrants bother trying to break in, which effectively freezes the competitive landscape in place. That stability has helped Autozone quietly retire roughly 90 percent of its shares over the past two decades, a staggering reduction that has mechanically supercharged earnings per share. The market never rewarded the company with a high multiple, but management turned that to its advantage by buying stock at consistently attractive valuations. The result has been more than 20 percent compound annual EPS growth for twenty years, an outcome most “high growth” sectors would kill for. Autozone’s scale, distribution muscle, and operational consistency give it a moat far stronger than the dull industry label implies. In a world obsessed with disruption, this is a case study in how a steady, disciplined incumbent can deliver extraordinary long-term compounding.

Pitch Summary:
In our last letter we noted the uncertain political backdrop this year, with elections creating a wide range of outcomes and implications for markets. One which we didn’t anticipate was the French National Assembly elections, a surprise which caused a sell-off in French stocks and bonds, and an opportunity for us to increase our positions, which we took. In June two of our stocks, Vinci and Eiffage, fell as much as 15%, although they have already begun their recoveries. The primary concern was a new government led by the right-wing National Rally who have previously discussed nationalising France’s motorway concessions. Of course, quite the opposite has now happened as the left-wing alliance won more seats than anyone, although not a majority, resulting in a hung parliament. This is another reminder of our approach to macroeconomic affairs – predicting outcomes, and subsequent market reactions, has a high failure rate and is something we won’t attempt. Preparing for inevitable surprises and taking advantage of opportunities as they present themselves has a high success rate. Less “fortune favours the brave”, more “fortune favours the prepared”. That said, we do discuss below the risks of nationalisation (and why we believe they are incredibly low) and the upside potential for both companies over the next few years as the durable, non-motorway businesses continue to grow as a percentage of profits and value. Nationalisation Realisation Nationalisation involves taking assets that are owned in the private sector and bringing them onto the public balance sheet, which is actually a misnomer in this case where motorway assets were never actually owned by the private sector. The French state own all the “freehold” to the motorways in France, while the operation of certain motorways was privatised under concessions in 2006 which have fixed terms. To save money, the French government decided to delegate responsibility for finance, design, construction, maintenance and operation of the motorways to concession operating businesses. At the end of the concession the control of the motorways reverts to state control, debt free. In other words, if the government does nothing, control will revert to them anyway in around fifteen years. If a newly galvanised populist government did want to force the issue sooner, they have no realistic options other than to fully compensate the concession owners. It’s not immediately clear that this would be a good use of funds given it is simply a premium for getting control back early, resulting in a loss of billions in annual revenue coming from taxes that the concessionaries pay. The basic principle is that unilaterally altering the economics of the concession contract (itself a legally binding act of parliament) is not possible without fair compensation to the concessionaire. Legality & Precedent There are precedents of similar attempts in Europe to nationalise infrastructure assets and they have shown the difficulty of changing those contracts. In August 2018, Atlantia saw one of their bridges collapse, causing the death of 30 people. Despite a three-year process by various Italian governments to strip the operator of the contract, courts found in favour of Atlantia. If a company that hasn’t performed effective maintenance is still legally allowed to retain its concession, it seems likely that Vinci and Eiffage will be afforded similar protection. Especially given that toll roads in France have proven to be successful at providing well maintained and up-to-date infrastructure to the population, with low tariff hikes. During state control of the operating companies (2000 – 2006), tariffs rose +2.06% per year, compared to the era post the privatisation of the concessions where tariffs rose +1.80% per year. Moreover, a recently introduced additional tax from the Macron government (equating to 4.6% of revenues until 2030) is being challenged in court. Recently the French supreme court has allowed for hearings and a first decision on September 12th, sooner than expected. If this tax is overturned the possibility of nationalisation decreases further still. Government Costs The motorway contract provides clauses to legally repurchase the concession before expiry if this is in the best interest of the public. The timing is such that the earliest time possible would be a year after a decision is taken which, given the likelihood of deadlock in French parliament, could be three to four years’ time. The price to be paid is a function of the net present value of cash flows from the concession until expiry. Under reasonable assumptions the total cost to the government would be c. EUR 50bn, a prohibitive amount and frankly, at current share prices, a boon to both Vinci and Eiffage (these payouts representing 41% and 105% of total market cap today). That latter point is worth dwelling on – 100% of the value of Eiffage today is represented by the fair value of their motorway assets, which represent far less than half of the total value of the company. The final economic point is that, once nationalised, the state would likely lose EUR 7bn of annual tax receipts coming from the operators, while having to pay to maintain and expand the roads (with Vinci and Eiffage the most likely to manage that contract). Finally, 10-20% of the shares are owned by employees, with meaningful blue-collar representation on the register. Any undervalued asset appropriation would be a serious financial hit for workers and cause a major backlash. The Toll Road Business Model Both Vinci and Eiffage derive about 30% of their value from French motorway concessions, down from about 60% fifteen years ago. Given these assets have fixed lives (i.e. until the concession agreement expires) and the remaining 70% of the businesses are growing strongly, this proportion will mathematically continue to shrink over the next few years. There are two dynamics in the French toll roads we particularly like – inflation protection and structural growth. Tolls on the French motorway network benefit from contracted increases in inflation that amount to 70% of CPI, which becomes increasingly valuable as inflation risks return. Motorways also offer structural growth as more traffic, both light vehicles and heavy trucks, use the network. France is key to many trade routes in continental Europe and lorries are still a cost-effective way of moving freight. Over time traffic has grown steadily at 2%, and this is before any inflationary increase. The Other Side of the Road Both companies generate high levels of organic free cash flow and have shown incredible capital allocation over the past 25 years. Initially, when acquiring the concessions to diversify their civil works businesses and, more recently, their investments in broader infrastructure assets, energy contracting, renewable concessions and construction. These new businesses are performing very well, with record order books and rising margins, supporting strong growth for the foreseeable future. In effect, the cash flow from concessions have afforded these companies the opportunity to invest in a diverse range of new businesses with wide moats, and far longer duration than the concession assets themselves, resulting in major value creation for shareholders. Despite this, and due to the political overhang, they trade at the widest discount to intrinsic value of the past ten years. Morgan Stanley estimate Vinci’s upside to intrinsic value at 50%, and Eiffage’s at closer to 80%, similar to our own figures. Conclusion Fundamentals are strong, the stocks have never been cheaper, while business mix is improving. With strong balance sheets and growing dividend yields already approaching 5% (compared to long-term averages of 3%), the outlook for capital returns and capital investment are strong. Exposure to global growth themes such as rising air traffic, the energy transition and the need to replace and improve infrastructure will support growth over the next decade, with very limited competitive threats. We believe the upside potential for shareholders is currently material, and we earn defensive, inflation-linked cash flows while we wait. As ever, please get in touch with anyone in the team if you have any questions. Best wishes from all of us at Latitude, Freddie Lait

BSD Analysis:
Vinci offers a rare blend of defensive, inflation-linked cash flows from French motorway concessions and attractive growth from airports and global contracting, yet trades at a discount to intrinsic value and to private infrastructure transaction multiples. The manager argues that nationalisation risk is remote: the state already owns the underlying assets, would have to fully compensate concession holders under EU and French law, and would lose sizeable annual tax receipts while assuming operating capex risks. With motorway exposure now roughly one-third of group value and shrinking, Vinci is increasingly driven by higher-growth, long-duration infrastructure and energy projects built on a 25-year track record of disciplined capital allocation. Cash flows comfortably fund a growing dividend yield approaching mid-single digits and ongoing reinvestment, keeping leverage in a prudent range. On low-teens earnings and cash-flow multiples for a business of this quality, the risk-reward skews positively if political overhang fades and investors refocus on fundamentals. Catalysts include a favourable court ruling on the Macron windfall tax, continued growth in airport traffic and energy transition capex, and any renewed appetite for listed infrastructure from long-term capital.

Pitch Summary:
The company is selling GLP-1 weight loss injection without FDA approval; reliant on a sole supplier that is previously related to fraud and bankruptcy; legal liability; chief executives cashed out $26mil since the drug announcement; Update 12/31/24 - Follow-up: GLP-1 shortage will be eliminated shortly.

BSD Analysis:
Hims & Hers Health provides telehealth and subscription-based treatments for wellness, sexual health, and mental health. The bear case stresses customer acquisition cost inflation, limited clinical differentiation, and regulatory oversight in prescribing practices. Growth has been fueled by aggressive marketing rather than durable competitive advantages. Profitability remains narrow, and questions around churn raise sustainability risks. Regulatory tightening could materially alter the cost structure.

Pitch Summary:
The company uses dishones and fraudulent ads to collect data and sell those data; ongoing investigation by FTC due to deceptive practices; sham health insurance policies; insiders are dumping shares due to significant adverse effect from the investigations;

BSD Analysis:
MediaAlpha operates an ad marketplace primarily serving insurance carriers. The BSD short thesis emphasizes dependency on cyclical insurer ad spend, regulatory headwinds on lead-gen, and fragile unit economics. Insurance companies have sharply cut back marketing budgets amid claims cost inflation, hurting MAX’s revenue base. Longer term, insurers investing in direct-to-consumer digital channels could structurally reduce reliance on third-party aggregators. While bulls highlight a rebound opportunity, bears argue valuation still implies growth resilience not supported by fundamentals. Investors should watch TAC (traffic acquisition cost) ratios, insurer ad budgets, and evolving regulations.

Pitch Summary:
Mereo BioPharma recently announced promising late-stage data for its lead asset, yet its stock is trading below previous highs and even below the price of a recent oversubscribed private placement. The market appears to be undervaluing the company's potential, especially given the backing of significant hedge funds and insiders.

BSD Analysis:
Mereo BioPharma's current valuation does not reflect the potential upside from its promising late-stage clinical data. The company's strategic investors, including Rubric Capital, which holds significant board influence, suggest confidence in the company's future prospects. The biotech sector often requires a catalyst for re-rating, and Mereo's recent data could serve as such a trigger. Furthermore, the company's focus on rare diseases positions it well in a niche market with less competition and potentially high margins. Investors should consider the broader biotech market dynamics, where many firms are undervalued due to a lack of immediate catalysts, presenting opportunities for those willing to wait for market recognition.

Pitch Summary:
Barfresh is positioned to disrupt the school meal industry with its USDA-approved ready-to-drink smoothies, capturing a significant market share in a short time. Despite operational setbacks, including a bottling crisis and supply chain issues, the company is poised for a strong recovery and growth, with management guiding for record revenues and profitability in 2024. The company's unique product, Twist & Go, has no direct competition and has been well-received in schools, leading to increased breakfast participation rates. Barfresh's expansion strategy includes increasing its presence in schools, entering new markets, and potentially launching in retail channels. The company has a credible path to achieving $100M in revenue in the next 3-5 years, with significant upside potential.

BSD Analysis:
Barfresh's strategic collaboration with the USDA and its focus on healthy, tasty breakfast items position it uniquely in the school meals market. The company's ability to quickly adapt to challenges, such as the COVID-19 pandemic and supply chain disruptions, demonstrates resilience and operational agility. The expansion into new markets and products, coupled with a strong brokerage network and sales team, supports its growth trajectory. While operational execution remains a risk, recent hires and capacity expansions suggest management is addressing these issues. The potential for significant revenue growth in the education channel, along with opportunities in the military and entertainment sectors, provides multiple avenues for future growth.